您的位置: 首页 > 农业专利 > 详情页

A LIQUID FORMULATION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE
专利权人:
HANMI PHARM. CO.; LTD.
发明人:
LIM, HYUNG KYU,KIM, HYUN UK,LEE, MI KYOUNG,LEE, JONG SOO,BAE, SUNG MIN,KWON, SE CHANG
申请号:
EP13822545
公开号:
EP2877201A4
申请日:
2013.07.25
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
The present invention relates to a liquid formulation of a combination of long-acting insulin and insulinotropic peptide, comprising insulin which is a physiologically active peptide, insulinotropic peptide, and albumin-free stabilizer, wherein the stabilizer comprises a buffer, a sugar alcohol, a non-ionic surfactant, and an isotonic agent and a method for preparing the liquid formulation. The liquid formulation of the present invention does not contain a human serum albumin and potentially toxic factors to the body, and thus it has excellent storage stability for insulin conjugate and insulinotropic peptide conjugate at high concentration, without a risk of viral contamination.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充